Bingchen Han et al reported that expression of FOXC1 was correlated with Gli2 expression and its downstream targets in breast cancers, and that FOXC1 maintained CSC properties in BLBC cells in Vivo and in Vitro by mediating non-canonica Gli2-Hh signal pathway [20]. The gene discussed is GLI2; the disease is breast carcinoma.